Table of Contents
India Launches New Made-in-India Td Vaccine
Introduction
- Launch Date – On 21 February 2026, the new Indian-made Td vaccine was officially started for public use.
- Minister Presence – Union Health Minister Jagat Prakash Nadda was present and led the launch programme.
- Launch Venue – The programme was held at Central Research Institute, Kasauli in Himachal Pradesh.
- Historic Moment – The minister called it a very important and historic day for the country.
- Self-Reliance Push – This step shows India’s effort to become self-reliant in the health sector.
- Public Health Milestone – It is seen as a big step in improving India’s public health system.
Indigenous Vaccine Launch
- Indian-Made Vaccine – The Td vaccine has been fully developed and produced in India.
- Disease Protection – It protects people from tetanus and adult diphtheria.
- Serious Illnesses – Both tetanus and diphtheria are dangerous bacterial diseases and can cause death if not treated on time.
- Old Vaccine Replaced – This vaccine replaces the older Tetanus Toxoid (TT) vaccine.
- Better Protection – Unlike the old vaccine that protected only against tetanus, this one gives protection from two diseases.
- Global Standards – The change has been made according to international health guidelines.
Universal Immunisation Programme (UIP)
- Added To UIP – The new Td vaccine is now part of India’s Universal Immunisation Programme.
- Largest Programme – The UIP is the biggest vaccination programme in the world.
- Many Diseases Covered – Under UIP, protection is given against 11 serious diseases through 12 different vaccines.
- Dose Supply Plan – CRI will provide about 55 lakh (5.5 million) doses of this vaccine.
- Deadline Set – These doses are expected to be supplied by April 2026.
- Production Increase – In the coming years, production will be increased further.
- Main Beneficiaries – The vaccine will mainly benefit teenagers and adults across the country.
Public Health Benefits
- Ongoing Risk – Tetanus and diphtheria are still present and can spread if people are not protected.
- Immunity Weakens – Protection from earlier vaccines becomes weak over time if booster doses are not taken.
- Low Booster Rates – In some places, many adults do not take booster doses, which increases risk.
- Stronger Immunity – The Td vaccine gives better and combined protection against both diseases.
- Fewer Cases Expected – Health experts believe this will reduce the number of disease cases.
- Teen Protection – Teenagers will get stronger protection through regular vaccination.
- Adult Safety – Adults will also be better protected from these infections.
National Health Security
- Safer Nation – This step makes the country stronger in handling health needs.
- Less Imports – India will not need to depend much on other countries for this vaccine.
- Global Reputation – India is often called the “pharmacy of the world” because it supplies medicines and vaccines worldwide.
- Large Production – India is one of the biggest vaccine producers in the world.
- WHO Recognition – India’s vaccine system has received Maturity Level 3 recognition from the World Health Organization.
- High Quality Control – This shows that India follows strong safety and quality rules in vaccine production.
Atmanirbhar Bharat Vision
- Self-Reliant Aim – The vaccine launch supports the Atmanirbhar Bharat goal of becoming self-dependent.
- Government Institutes – Government institutions played an important role in developing the vaccine.
- CRI Contribution – CRI Kasauli led the production work.
- Safety Standards – The vaccine has been produced following Good Manufacturing Practices (GMP).
- Modern Facilities – Efforts have been made to modernise vaccine production centres.
- More Vaccines Planned – The government plans to produce more vaccines within the country.
- Research Growth – More focus is being given to research and development in India.
Covid-19 Lessons
- Pandemic Learning – India gained valuable experience during the Covid-19 pandemic.
- Quick Development – Two Indian Covid-19 vaccines were developed within nine months.
- Mass Vaccination Drive – More than 220 crore vaccine doses were given across the country.
- Stronger System – This experience made India’s vaccine system stronger.
- Future Ready – India is now better prepared for future health emergencies.
- Digital Tracking – Digital systems were used to track vaccination and provide certificates.
Broader Health Efforts
- Large Coverage – Around 5 crore people benefit from vaccination every year.
- Digital Monitoring – Vaccinations are tracked through digital systems like U-WIN.
- Better Maternal Care – The programme is linked to better health care for mothers.
- Safe Deliveries – It has helped increase the number of safe hospital deliveries.
- Health Insurance Support – It is supported by government schemes such as Ayushman Bharat – PMJAY.
- Ongoing Reforms – The launch is part of larger health sector improvements.
Important Questions
- Who launched the indigenous Td vaccine and where was it launched?
- Which two diseases does the new Td vaccine protect against?
- Why was the older Tetanus Toxoid (TT) vaccine replaced with the Td vaccine?
- How will including the Td vaccine in the Universal Immunisation Programme benefit people?
- How does the launch of the indigenous Td vaccine support India’s goal of self-reliance in healthcare?
Conclusion
The launch of the Indian-made Td vaccine at the Central Research Institute in Kasauli is an important step for India’s healthcare system. It provides better protection against tetanus and diphtheria, reduces dependence on other countries, and strengthens the country’s vaccination programme. This move shows India’s growing ability to produce its own vaccines and protect the health of its people.
Download Online Mock Test Mobile APP
3
